Chimeric Antigen Receptor Engineered T Cells and Their Application in the Immunotherapy of Solid Tumors

By
Justin.choi
-
0
174
With several hundred clinical trials undergoing worldwide, the pace that CAR-T immunotherapy moves from bench to bedside is unprecedented.
[Expert Reviews in Molecular Medicine]

Sorry, but the selected Zotpress account can't be found.

Abstract